Lyu J - Search Results

1

Naphthofuroquinone derivatives show strong antimycobacterial activities against drug-resistant Mycobacteria.

Jang WS, Choi YS, Kim S, Jyoti MA, Seo H, Han J, Kim YS, Lyu J, Nam KW, Lee BE, Lee KI, Song HY. Jang WS, et al. Among authors: lyu j. J Chemother. 2017 Dec;29(6):338-343. doi: 10.1080/1120009X.2017.1296987. Epub 2017 Mar 10. J Chemother. 2017. PMID: 28281912

2

Daily 300 mg dose of linezolid for multidrug-resistant and extensively drug-resistant tuberculosis: updated analysis of 51 patients.

Koh WJ, Kang YR, Jeon K, Kwon OJ, Lyu J, Kim WS, Shim TS. Koh WJ, et al. Among authors: lyu j. J Antimicrob Chemother. 2012 Jun;67(6):1503-7. doi: 10.1093/jac/dks078. Epub 2012 Mar 8. J Antimicrob Chemother. 2012. PMID: 22403262 Free article.

3

GenoType® MTBDRplus assay detection of drug-resistant tuberculosis in routine practice in Korea.

Lyu J, Kim MN, Song JW, Choi CM, Oh YM, Lee SD, Kim WS, Kim DS, Shim TS. Lyu J, et al. Int J Tuberc Lung Dis. 2013 Jan;17(1):120-4. doi: 10.5588/ijtld.12.0197. Int J Tuberc Lung Dis. 2013. PMID: 23232012

4

In Vitro Effect of DFC-2 on Mycolic Acid Biosynthesis in Mycobacterium tuberculosis.

Kim S, Seo H, Mahmud HA, Islam MI, Kim YS, Lyu J, Nam KW, Lee BE, Lee KI, Song HY. Kim S, et al. Among authors: lyu j. J Microbiol Biotechnol. 2017 Nov 28;27(11):1932-1941. doi: 10.4014/jmb.1705.05013. J Microbiol Biotechnol. 2017. PMID: 28870005 Free article.

5

A shorter treatment duration may be sufficient for patients with Mycobacterium massiliense lung disease than with Mycobacterium abscessus lung disease.

Lyu J, Kim BJ, Kim BJ, Song JW, Choi CM, Oh YM, Lee SD, Kim WS, Kim DS, Shim TS. Lyu J, et al. Respir Med. 2014 Nov;108(11):1706-12. doi: 10.1016/j.rmed.2014.09.002. Epub 2014 Sep 16. Respir Med. 2014. PMID: 25245792 Free article.

6

Distinguishing tuberculosis from Mycobacterium avium complex disease using an interferon-gamma release assay.

Ra SW, Lyu J, Choi CM, Oh YM, Lee SD, Kim WS, Kim DS, Shim TS. Ra SW, et al. Among authors: lyu j. Int J Tuberc Lung Dis. 2011 May;15(5):635-40. doi: 10.5588/ijtld.10.0485. Int J Tuberc Lung Dis. 2011. PMID: 21756514

7

Combined use of a TST and the T-SPOT®.TB assay for latent tuberculosis infection diagnosis before anti-TNF-α treatment.

Jung YJ, Lyu J, Yoo B, Lee CK, Kim YG, Yang SK, Byeon JS, Kim KJ, Ye BD, Lee KH, Lee SD, Kim WS, Kim DS, Shim TS. Jung YJ, et al. Among authors: lyu j. Int J Tuberc Lung Dis. 2012 Oct;16(10):1300-6. doi: 10.5588/ijtld.12.0004. Epub 2012 Aug 3. Int J Tuberc Lung Dis. 2012. PMID: 22863375

8

Non-tuberculous mycobacterial diseases presenting as solitary pulmonary nodules.

Lim J, Lyu J, Choi CM, Oh YM, Lee SD, Kim WS, Kim DS, Lee H, Shim TS. Lim J, et al. Among authors: lyu j. Int J Tuberc Lung Dis. 2010 Dec;14(12):1635-40. Int J Tuberc Lung Dis. 2010. PMID: 21144251

9

Chest computed tomography is more likely to show latent tuberculosis foci than simple chest radiography in liver transplant candidates.

Lyu J, Lee SG, Hwang S, Lee SO, Cho OH, Chae EJ, Lee SD, Kim WS, Kim DS, Shim TS. Lyu J, et al. Liver Transpl. 2011 Aug;17(8):963-8. doi: 10.1002/lt.22319. Liver Transpl. 2011. PMID: 21506252 Free article.

10

Early discontinuation of ethambutol in pulmonary tuberculosis treatment based on results of the GenoType MTBDRplus assay: A prospective, multicenter, non-inferiority randomized trial in South Korea.

Jo KW, Kim M, Kim YJ, Lee HK, Kim HK, Jeon D, Lyu J, Park HK, Mok J, Kim JS, Heo EY, Choi SB, Yim JJ, Shim TS. Jo KW, et al. Among authors: lyu j. Antimicrob Agents Chemother. 2019 Sep 19;63(12):e00980-19. doi: 10.1128/AAC.00980-19. Epub 2019 Sep 16. Antimicrob Agents Chemother. 2019. PMID: 31527020 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,256 results

Search Page